Learn More
Medchemexpress LLC Erenapurstat | 136164-66-4 | 99.67% | 378.46 | 50 MG

Supplier: Medchemexpress LLC HY1935750MG
Erenapurstat (E3330) is a direct, orally active and selective inhibitor of Ape-1 (apurinic/apyrimidinic endonuclease 1)/Ref-1 (redox factor-1) redox. It impairs tumor growth and blocks the activity of NF-κB, AP-1, and HIF-1α in pancreatic cancer, showing anticancer activities.
- Targets Ape-1 and Ref-1
- Inhibits growth of HUVECs, PCECs, and EPCs
- Reduces VEGF expression in pancreatic cancer cells
- Inhibits differentiation of BM-MSCs into CD31+ endothelial lineage cells
- Decreases cell viability in H1975 cells
- Inhibits growth and migration of pancreatic cancer cells
- Enhances intracellular ROS level and inhibits CD44 expression in PANC1 cells
- Neuroprotective against cisplatin-induced alterations
- Attenuates liver injury in rats
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.